<International Circulation>:  What do you think is the major factor when considering selection of DES or BMS for patients with AMI?

Prof. Smits: This is a very serious and important topic. Stent thrombosis is enhanced in acute coronary syndrome so your stent selection should be focused on the specific problem of stent thrombosis. In that regard， I think that bare-metal stents have an advantage compared to certain drug-eluting stents. However， I do believe that certain drug-eluting stents are comparable and potentially even better in preventing stent thrombosis in patients who present with AMI.